Editorial: Advancements and challenges in CAR-T cell therapy for cancer treatment
Frontiers in Pharmacology · 09.04.2026 · 17
DOI: 10.3389/fphar.2026.1820259 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.04.2026. Verfasst von Alexander T Sougiannis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wexner Medical Center, The Ohio State University, Columbus, OH, United States. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
- Universidad Autonoma del Estado de Morelos, Cuernavaca, Mexico.
- Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, SC, United States.
- Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.
Zitieren
APA
Sougiannis, A. T., Meneses Acosta, A., & Ferreira, L. M. R. (2026). Editorial: Advancements and challenges in CAR-T cell therapy for cancer treatment. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1820259
Vancouver
Sougiannis AT, Meneses Acosta A, Ferreira LMR. Editorial: Advancements and challenges in CAR-T cell therapy for cancer treatment. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1820259
BibTeX
@article{Sougiannis2026,
author = {Sougiannis, Alexander T and Meneses Acosta, Angelica and Ferreira, Leonardo M R},
title = {Editorial: Advancements and challenges in CAR-T cell therapy for cancer treatment},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1820259}
}
EUVIMED